TMPRSS2 and prostate carcinoma: Lee et al. proposed using oligonucleotide‐functionalized quantum dots and magnetic microparticles for optical detection of rearranged TMPRSS2: ERG fusion genes at low concentrations in buffer, urine, and prostate cancer cells (LNCaP and NCI‐H660 cell lines) to develop an assay for prostate cancer diagnosis.179